A short-term VEGF-A injection into the ventricles improves cell proliferation in the SVZ and DG 28 days post stroke and is significant for functional recovery after a stroke by increasing angiogenesis and neurogenesis [24]. The gene discussed is VEGFA; the disease is stroke disorder.